Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Deininger

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Clinical Case Reports|June 12, 2019
Lysozyme nephropathy in chronic myelomonocytic leukemiaAmi B Patel, Rodney R Miles, Michael W Deininger
Cancer Medicine|August 9, 2023
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemiaMay Garrett, Beverly Knight, Jorge E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?Dongqing Yan, Anthony D Pomicter, Thomas O'Hare, et al.
BMC Medicine|August 27, 2011
Advances in the treatment of chronic myeloid leukemiaAnna M Eiring, Jamshid S Khorashad, Kimberly Morley, et al.
Current Hematologic Malignancy Reports|August 31, 2017
Minimal Residual Disease Eradication in CML: Does It Really Matter?Srinivas K Tantravahi, Raga S Guthula, Thomas O'Hare, et al.
Clinical Lymphoma & Myeloma|March 4, 2009
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?Jennifer L Snead, Thomas O'Hare, Christopher A Eide, et al.
Nature Reviews. Cancer|July 25, 2012
Pushing the limits of targeted therapy in chronic myeloid leukaemiaThomas O'Hare, Matthew S Zabriskie, Anna M Eiring, et al.
Experimental Hematology|March 18, 2006
Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemiaShadmehr Demehri, Amie Corbin, Marc Loriaux, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
Blood|August 23, 2007
Therapeutic drug monitoring in CML patients on imatinibCarolyn Blasdel, Merrill J Egorin, Theodore F Lagattuta, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Clinical Case Reports|June 12, 2019
Lysozyme nephropathy in chronic myelomonocytic leukemiaAmi B Patel, Rodney R Miles, Michael W Deininger
Cancer Medicine|August 9, 2023
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemiaMay Garrett, Beverly Knight, Jorge E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?Dongqing Yan, Anthony D Pomicter, Thomas O'Hare, et al.
BMC Medicine|August 27, 2011
Advances in the treatment of chronic myeloid leukemiaAnna M Eiring, Jamshid S Khorashad, Kimberly Morley, et al.
Current Hematologic Malignancy Reports|August 31, 2017
Minimal Residual Disease Eradication in CML: Does It Really Matter?Srinivas K Tantravahi, Raga S Guthula, Thomas O'Hare, et al.
Clinical Lymphoma & Myeloma|March 4, 2009
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?Jennifer L Snead, Thomas O'Hare, Christopher A Eide, et al.
Nature Reviews. Cancer|July 25, 2012
Pushing the limits of targeted therapy in chronic myeloid leukaemiaThomas O'Hare, Matthew S Zabriskie, Anna M Eiring, et al.
Experimental Hematology|March 18, 2006
Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemiaShadmehr Demehri, Amie Corbin, Marc Loriaux, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
Blood|August 23, 2007
Therapeutic drug monitoring in CML patients on imatinibCarolyn Blasdel, Merrill J Egorin, Theodore F Lagattuta, et al.
Pageof 16